Back
MiNK Therapeutics, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
32
INKT
MiNK Therapeutics, Inc.
Last Price:
$11.68
Seasonality Move:
-18.07%
7 Day Trial
ALL ACCESS PASS
$
7
MiNK Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, MiNK Therapeutics, Inc. has on average historically fallen by 16% based on the past 4 years of stock performance.
-
MiNK Therapeutics, Inc. has fallen lower in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
-
Is MiNK Therapeutics, Inc. Stock Undervalued?The current MiNK Therapeutics, Inc. [INKT] share price is $11.59. The Score for INKT is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
-
INKT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will MiNK Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, MiNK Therapeutics, Inc. has on average historically fallen by 16% based on the past 4 years of stock performance.
MiNK Therapeutics, Inc. Stock Rating
Sell
32
MiNK Therapeutics, Inc. (INKT)
is a Sell
Is MiNK Therapeutics, Inc. overpriced?
-
MiNK Therapeutics, Inc. has fallen lower in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
MiNK Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
minktherapeutics.com
52-Week Data
52-Week High:
76.00
52-Week Low:
4.56
Prediction Charts
Market Cap:
54.4M
Price in USD:
11.59
Volume:
32.1K
Beta:
0.34
Technical Analysis
SMA50:
12.80
SMA100:
13.69
SMA200:
11.89
52-Wk Change:
131.71%
Stock Predictions
-
Is MiNK Therapeutics, Inc. stock public?Yes, MiNK Therapeutics, Inc. is a publicly traded company.
-
What is the MiNK Therapeutics, Inc. stock quote today?The MiNK Therapeutics, Inc. stock price is 11.59 USD today.
-
How to buy MiNK Therapeutics, Inc. stock online?You can buy MiNK Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-2 | 10.77 | 10.72 | 11.10 | 10.72 |
| Dec-3 | 10.72 | 10.93 | 11.06 | 10.72 |
| Dec-4 | 10.92 | 12.35 | 12.50 | 10.51 |
| Dec-5 | 12.27 | 11.50 | 12.38 | 11.50 |
| Dec-8 | 11.62 | 12.01 | 12.14 | 11.48 |
| Dec-9 | 12.49 | 12.99 | 13.20 | 11.51 |
| Dec-10 | 13.17 | 12.74 | 13.34 | 12.36 |
| Dec-11 | 12.78 | 12.55 | 12.78 | 12.30 |
| Dec-12 | 12.69 | 12.42 | 12.83 | 12.25 |
| Dec-15 | 12.56 | 12.18 | 12.61 | 12.12 |
| Dec-16 | 12.13 | 11.96 | 12.68 | 11.55 |
| Dec-17 | 11.91 | 11.71 | 12.37 | 11.71 |
| Dec-18 | 11.93 | 11.53 | 11.93 | 11.50 |
| Dec-19 | 11.59 | 11.59 | 11.91 | 10.99 |
MiNK Therapeutics, Inc. Earnings
MiNK Therapeutics, Inc. Earnings Report: Per Share MiNK Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
MiNK Therapeutics, Inc. Forecast Revenue Growth
MiNK Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for MiNK Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.40 per share, and a decrease next year of $0.82 per share.
* MiNK Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.